Melexis Balance Sheet Health
Financial Health criteria checks 4/6
Melexis has a total shareholder equity of €602.0M and total debt of €173.5M, which brings its debt-to-equity ratio to 28.8%. Its total assets and total liabilities are €893.6M and €291.6M respectively. Melexis's EBIT is €263.9M making its interest coverage ratio 35.5. It has cash and short-term investments of €35.7M.
Key information
28.8%
Debt to equity ratio
€173.48m
Debt
Interest coverage ratio | 35.5x |
Cash | €35.66m |
Equity | €602.00m |
Total liabilities | €291.57m |
Total assets | €893.57m |
Recent financial health updates
Melexis (EBR:MELE) Has A Pretty Healthy Balance Sheet
Jan 02Does Melexis (EBR:MELE) Have A Healthy Balance Sheet?
Sep 17Does Melexis (EBR:MELE) Have A Healthy Balance Sheet?
Sep 15These 4 Measures Indicate That Melexis (EBR:MELE) Is Using Debt Safely
Jun 08Does Melexis (EBR:MELE) Have A Healthy Balance Sheet?
Feb 15Recent updates
Calculating The Fair Value Of Melexis NV (EBR:MELE)
Mar 27At €78.60, Is Melexis NV (EBR:MELE) Worth Looking At Closely?
Mar 14Many Would Be Envious Of Melexis' (EBR:MELE) Excellent Returns On Capital
Feb 28Melexis' (EBR:MELE) Solid Earnings May Rest On Weak Foundations
Feb 15Melexis (EBR:MELE) Has A Pretty Healthy Balance Sheet
Jan 02What Does Melexis NV's (EBR:MELE) Share Price Indicate?
Dec 09Here's Why Melexis (EBR:MELE) Has Caught The Eye Of Investors
Nov 27Melexis (EBR:MELE) Knows How To Allocate Capital
Nov 15Calculating The Intrinsic Value Of Melexis NV (EBR:MELE)
Nov 03Melexis' (EBR:MELE) Dividend Will Be €0.91
Oct 10Melexis (EBR:MELE) Is Due To Pay A Dividend Of €0.91
Sep 26Does Melexis (EBR:MELE) Have A Healthy Balance Sheet?
Sep 17Melexis (EBR:MELE) Has Announced A Dividend Of €0.91
Sep 02Melexis (EBR:MELE) Has Announced A Dividend Of €0.91
Aug 19Melexis' (EBR:MELE) Dividend Will Be €0.91
Aug 05Melexis (EBR:MELE) Might Become A Compounding Machine
Jul 13Do Melexis' (EBR:MELE) Earnings Warrant Your Attention?
Jun 29Estimating The Intrinsic Value Of Melexis NV (EBR:MELE)
Jun 02At €99.75, Is Melexis NV (EBR:MELE) Worth Looking At Closely?
Apr 11With EPS Growth And More, Melexis (EBR:MELE) Makes An Interesting Case
Mar 27Is It Time To Consider Buying Melexis NV (EBR:MELE)?
Jan 09Here's Why Melexis (EBR:MELE) Has Caught The Eye Of Investors
Dec 24Is Melexis NV (EBR:MELE) Expensive For A Reason? A Look At Its Intrinsic Value
Nov 24Melexis (EBR:MELE) Is Paying Out A Dividend Of €0.91
Oct 18Melexis' (EBR:MELE) Dividend Will Be €0.91
Oct 04Melexis' (EBR:MELE) Dividend Will Be €0.91
Sep 20We Ran A Stock Scan For Earnings Growth And Melexis (EBR:MELE) Passed With Ease
Sep 19Melexis' (EBR:MELE) Dividend Will Be €0.91
Sep 05Melexis (EBR:MELE) Is Due To Pay A Dividend Of €0.91
Aug 22Melexis (EBR:MELE) Will Pay A Dividend Of €0.91
Aug 04Is There An Opportunity With Melexis NV's (EBR:MELE) 31% Undervaluation?
Jul 11Melexis (EBR:MELE) Looks To Prolong Its Impressive Returns
Jun 27Does Melexis (EBR:MELE) Deserve A Spot On Your Watchlist?
Jun 13Should You Think About Buying Melexis NV (EBR:MELE) Now?
Mar 01Calculating The Fair Value Of Melexis NV (EBR:MELE)
Feb 14Melexis (EBR:MELE) Looks To Prolong Its Impressive Returns
Dec 06Should You Think About Buying Melexis NV (EBR:MELE) Now?
Nov 18Is Melexis NV (EBR:MELE) Expensive For A Reason? A Look At Its Intrinsic Value
Sep 29Does Melexis (EBR:MELE) Have A Healthy Balance Sheet?
Sep 15Melexis (EBR:MELE) Will Be Hoping To Turn Its Returns On Capital Around
Jul 18Is It Time To Consider Buying Melexis NV (EBR:MELE)?
Jun 21These 4 Measures Indicate That Melexis (EBR:MELE) Is Using Debt Safely
Jun 08Melexis NV's (EBR:MELE) Intrinsic Value Is Potentially 20% Below Its Share Price
Apr 11What Is The Ownership Structure Like For Melexis NV (EBR:MELE)?
Mar 17Is Melexis (EBR:MELE) Likely To Turn Things Around?
Feb 28Does Melexis (EBR:MELE) Have A Healthy Balance Sheet?
Feb 15Consider This Before Buying Melexis NV (EBR:MELE) For The 2.8% Dividend
Feb 01Has Melexis NV's (EBR:MELE) Impressive Stock Performance Got Anything to Do With Its Fundamentals?
Jan 18Financial Position Analysis
Short Term Liabilities: MELE's short term assets (€457.4M) exceed its short term liabilities (€109.6M).
Long Term Liabilities: MELE's short term assets (€457.4M) exceed its long term liabilities (€182.0M).
Debt to Equity History and Analysis
Debt Level: MELE's net debt to equity ratio (22.9%) is considered satisfactory.
Reducing Debt: MELE's debt to equity ratio has increased from 10.3% to 28.8% over the past 5 years.
Debt Coverage: MELE's debt is not well covered by operating cash flow (1.5%).
Interest Coverage: MELE's interest payments on its debt are well covered by EBIT (35.5x coverage).